Kimberly Anne Bertrand ScD
Associate Professor, Preventive Medicine & Epidemiology
Associate Professor, Slone Epidemiology Center
72 E. Concord Street | (617) 206-6174kab15@bu.edu
Sections
Preventive Medicine & Epidemiology
Centers
BU-BMC Cancer Center
Biography
Dr. Bertrand’s research focuses primarily on the epidemiology of breast cancer, with an emphasis on understanding racial disparities in incidence and outcomes. She is currently Multiple Principal Investigator of the Black Women’s Health Study (BWHS), a prospective cohort study of over 59,000 African American women begun in 1995. Dr. Bertrand is also Principal Investigator of a BWHS study to evaluate risk factors for high mammographic density, a strong independent predictor of breast cancer, and the role mammographic density and other risk factors may play in tumor aggressiveness. Other areas of research interest include risk factors for non-Hodgkin lymphoma and multiple myeloma.
Other Positions
Education
Epidemiology, ScD, Harvard School of Public Health
Epidemiology, MPH, Boston University School of Public Health
Biology, BS, Brown University
Publications
Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gallagher G, Gierach GL, Goodman MT, Jordan SJ, La Vecchia C, Lacey JV, Levi F, Liao LM, Lipworth L, Lu L, Matías-Guiu X, Moysich KB, Mutter GL, Na R, Naduparambil J, Negri E, O'Connell K, O'Mara TA, Onieva Hernández I, Palmer JR, Parazzini F, Patel AV, Penney KL, Prizment AE, Ricceri F, Risch HA, Sacerdote C, Sandin S, Stolzenberg-Solomon RZ, van den Brandt PA, Webb PM, Wentzensen N, Wijayabahu AT, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Du M, Setiawan VW. Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev. 2024 Mar 26. PMID: 38530242.
Published on 2/29/2024Troisi R, Bertrand K, Hatch EE, Strohsnitter WC, Aagaard K, Robboy SJ, Gierach G, Titus L. An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract. Obstet Gynecol. 2024 Apr 01; 143(4):603-606. PMID: 38422500.
Published on 2/19/2024Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545. PMID: 38377945.
Published on 1/12/2024Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the Black Women's Health Study. Br J Cancer. 2024 Mar; 130(5):830-835. PMID: 38212484.
Published on 1/10/2024Wolfson EA, Schonberg MA, Eliassen AH, Bertrand KA, Shvetsov YB, Rosner BA, Palmer JR, LaCroix AZ, Chlebowski RT, Nelson RA, Ngo LH. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older. J Natl Cancer Inst. 2024 Jan 10; 116(1):81-96. PMID: 37676833.
Published on 1/9/2024Bertrand KA, Szalat R. Deciphering racial disparities in multiple myeloma outcomes. Blood Adv. 2024 Jan 09; 8(1):234-235. PMID: 38194241.
Published on 1/2/2024Zirpoli GR, Pfeiffer RM, Bertrand KA, Huo D, Lunetta KL, Palmer JR. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Res. 2024 Jan 02; 26(1):2. PMID: 38167144.
Published on 12/11/2023Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 2024 Mar 10; 42(8):927-939. PMID: 38079601.
Published on 11/1/2023Tehranifar P, Bertrand KA. Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities. Cancer Epidemiol Biomarkers Prev. 2023 Nov 01; 32(11):1479-1481. PMID: 37908191.
Published on 10/10/2023Bertrand KA, Delp L, Coogan PF, Cozier YC, Lenzy YM, Rosenberg L, Palmer JR. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study. Environ Res. 2023 Dec 15; 239(Pt 1):117228. PMID: 37821068.
Media Mentions
Published on 2/29/2024
FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late
Published on 2/7/2024
FDA Move to Ban Hair Relaxer Chemical Called Too Little, Too Late
Published on 2/6/2024
FDA move to ban formaldehyde in hair straighteners called too little, too late
Published on 12/12/2023
Can using everyday hair care products be harmful to your health?
Published on 12/5/2023
'It's long overdue': Local salons react to FDA proposal to ban hair relaxers
Published on 11/14/2023
Hair Straighteners and Relaxers May Be Harmful to Health. Here’s How to Make Them Better
Published on 11/2/2023
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer
Published on 11/1/2023
If You're Using Any of These Toxic Hair Products, Stop Now, FDA Warns`
Published on 11/1/2023
There’s a straight line between natural-hair discrimination and a higher risk of cancer
Published on 10/31/2023
View full list of 41 media mentions.